Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jan 5;58(2):211–225. doi: 10.3892/ijo.2021.5167

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Holzhauser et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

WST-1 viability assays on SK-N-AS, SK-N-BE(2)-C, SK-N-DZ, SK-N-FI and SK-N-SH cell lines upon treatment with cisplatin, vincristine and doxorubicin. WST-1 viability assay measured the absorbance following treatment for 24, 48 and 72 h of (A, F and K) SK-N-AS, (B, G and L) SK-N-BE(2)-C, (C, H and M) SK-N-DZ, (D, I and N) SK-N-FI, and (E, J and O) SK-N-SH cells treated with (A-E) cisplatin, (F-J) vincristine and (K-O) doxorubicin. The graphs represent 3 experimental runs per cell line and results are presented as the means ± standard deviation. CIS, cisplatin; VIN, vincristine; DOXO, doxorubicin.